ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $699,862 | +5.8% | 25,787 | +19.8% | 0.46% | +22.1% |
| Q2 2023 | $661,524 | +150.0% | 21,520 | +193.0% | 0.38% | +132.1% |
| Q1 2023 | $264,635 | +24.7% | 7,345 | +36.8% | 0.16% | +7.3% |
| Q4 2022 | $212,219 | -6.9% | 5,370 | -5.3% | 0.15% | -20.5% |
| Q3 2022 | $228,000 | -8.8% | 5,672 | -4.6% | 0.19% | -3.6% |
| Q2 2022 | $250,000 | -65.8% | 5,948 | -68.4% | 0.20% | -59.0% |
| Q1 2022 | $732,000 | -3.6% | 18,800 | -1.3% | 0.48% | -0.2% |
| Q4 2021 | $759,000 | +13.5% | 19,049 | +2.9% | 0.48% | +6.2% |
| Q3 2021 | $669,000 | +4.4% | 18,506 | +18.3% | 0.45% | +10.2% |
| Q2 2021 | $641,000 | +170.5% | 15,646 | +188.5% | 0.41% | +183.4% |
| Q1 2021 | $237,000 | – | 5,423 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |